Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Clinical Operations.Register Now
The Clinical Operations Roundtable Discussions Strategy Meeting is free to attend for qualified end-users. These include Senior Executives of Clinical Operations (from medium to large Pharma, Biopharma and Biotech players) as well as thought leaders from Academia and regulatory authorities.
Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
– Clinical Operations, Data Sciences, Clinical Outsourcing, Patient Recruitment, eTMF, Safety Data Management, Clinical Trial Management, Data Acquisition Technology and Integrations, Clinical, Pharmacology Scientific Operations, Clinical Informatics and Innovation.
Those who do not qualify for complimentary passes, including vendors, exchanges, consultancies and other service providers, can apply here.
Chief Development and Operations Officer, Karyopharm Therapeutics Inc.
Chief Medical Officer, Syndax Phamaceuticals
Chief Technology Officer, Gelesis
Global Head, Strategy and Operations, Clinical Development Quality, Novartis
Vice President, Therapeutics Operations, Moderna Therapeutics
Vice President, Global Clinical Operations, Biogen Idec
Executive Director Outsourcing & Contracts, Medical and Development, Astellas
Director Head of TMF Operations, Pfizer
Clinical Operations Strategy Meeting US 2017,
The Westin Boston Waterfront
425 Summer St, Boston, MA 02210